Effective vaccines against RSV are being launched to protect pregnant women, infants, and older adults. A new jab will be offered to those at risk of avian influenza. Moderna Inc's RSV shot mRESVIA showed 50% efficacy in preventing RSV after 18 months.
Moderna Inc respiratory syncytial virus (RSV) shot mRESVIA showed 50% efficacy in preventing RSV after 18 months, the drugmaker said on Wednesday. https://t.co/qJHkhsAmNO https://t.co/qJHkhsAmNO
Millions will be offered life-saving new jab to protect against 'severe' RSV free on the NHS - are you eligible? | The Sun https://t.co/QnVvo6XTQO
Older people and pregnant women will be offered a new NHS jab this year https://t.co/6ue1ok0OEd
"The vaccine will be offered to those aged 18 or over who are at increased risk of contracting avian influenza due to their work or other circumstances” https://t.co/FpW3ALpkiv
RSV is a nasty respiratory illness - hospitalising thousands each winter. But we now have effective vaccines. And after a successful tender, I'm delighted we are launching a campaign this Autumn to protect pregnant mums, their infants and older adults. https://t.co/tq2fOxJ3Rc